lanthanum has been researched along with Breast Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Jadhav, SH; Kulkarni-Dwivedi, N; Paknikar, KM; Patel, PR; Shravage, BV; Umrani, RD | 1 |
Kawaguchi, K; Kodama, R; Makino, M; Nagasawa, M; Nakamura, H; Shimojo, H | 1 |
Jesionowski, T; Jurga, S; Michalska, M; Nowaczyk, G; Peplińska, B; Przysiecka, Ł; Schneider, R | 1 |
Calabriso, N; De Pascali, SA; Fanizzi, FP; Marsigliante, S; Muscella, A; Storelli, C; Vetrugno, C | 1 |
Berger, W; Chiba, P; Dornetshuber, R; Elbling, L; Heffeter, P; Jakupec, MA; Keppler, BK; Körner, W; Micksche, M; Pirker, C; Sutterlüty, H | 1 |
5 other study(ies) available for lanthanum and Breast Neoplasms
Article | Year |
---|---|
Hyperthermia and doxorubicin release by Fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Female; Folic Acid; Humans; Hyperthermia, Induced; Lanthanum; Manganese; Nanoparticles; Reactive Oxygen Species; Strontium | 2022 |
Extensive lanthanum deposition in the gastric mucosa: the first histopathological report.
Topics: Adenocarcinoma; Breast Neoplasms; Female; Gastric Mucosa; Humans; Hyperphosphatemia; Lanthanum; Microscopy, Electron, Scanning; Middle Aged; Neoplasms, Second Primary; Renal Insufficiency, Chronic; Spectrometry, X-Ray Emission; Stomach Neoplasms | 2015 |
iRGD peptide as effective transporter of CuInZnxS2+x quantum dots into human cancer cells.
Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Proliferation; Copper; Drug Carriers; Female; HeLa Cells; Humans; Lanthanum; Microscopy, Electron, Transmission; Oligopeptides; Osteosarcoma; Quantum Dots; Spheroids, Cellular; Sulfides; Tumor Cells, Cultured; Zinc Compounds | 2016 |
The platinum (II) complex [Pt(O,O'-acac)(γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Calcium; Cell Line, Tumor; Cell Membrane; Cell Membrane Permeability; Dose-Response Relationship, Drug; Female; Homeostasis; Humans; Lanthanum; Organoplatinum Compounds; Plasma Membrane Calcium-Transporting ATPases; Protein Kinase C-alpha; Sodium-Calcium Exchanger | 2011 |
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Carcinoma, Small Cell; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Formazans; HL-60 Cells; Humans; Lanthanum; Lung Neoplasms; Molecular Structure; Neoplasm Proteins; Organic Anion Transporters; Organometallic Compounds; Phenanthrolines; Sensitivity and Specificity; Tetrazolium Salts | 2007 |